Search results for: Health Policy and Regulation

Let’s talk about (health) inequalities

1 April 2022

…for a better mechanism to inform decisions in the UK and elsewhere? Applied Health Economics and Health Policy, 19(5), pp.635-644. DOI: 10.1007/s40258-021-00648-2 Asada, Y., Abel, H., Skedgel, C. and Warner, G.,…

Around The World in HTAs: France – Three Core HTA Values

12 March 2026

The health system in France France has a mixed-type health system. Primarily based on social health insurance, it also incorporates elements of a national health system to ensure universality and solidarity…

About us

…healthcare efficiency, sustainability, and outcomes by: Generating original research and analysis For pragmatic solutions and stronger policy decisions. Promoting independent thinking To shape debate and create impact. Connecting industry and…

Atherosclerotic cardiovascular disease (ASCVD) costs the world $680 billion a year in healthcare – roughly the size of Sweden’s entire economy, new research finds 

31 March 2026

…forefront of all we do. OHE provides independent and pioneering resources, research and analyses in health economics, health policy and health statistics. Our work informs decision–making about health care and…

What is the future of health economics?

1 May 2023

…good. Health economics and the built environment may be an obvious one.” Health economists should not solely focus on health maximisation Anne Mills, Professor of Health Economics and Policy at…

Turning around the NHS: Reflections on the 2025 OHE Annual Lecture

14 October 2025

…needs improved population health, sustained productivity improvements in the NHS and the scale and spread of cost-effective innovation.  She pointed out that the policy directions in the 10 Year Health…

Climate action is health action: OHE’s focus on sustainability

22 July 2025

…and low-carbon transitions – decisions that carry health consequences, whether intended or not. OHE’s Work on Climate and Health We are exploring the impacts of climate and health across several…

Germany’s drug-pricing dilemma: Why Europe’s pivotal market holds the key to the MFN debate

25 June 2026

…States; it is between national affordability objectives and global innovation incentives, and it is visible across Europe. Governments want innovative medicines, thriving life-sciences sectors, investment and jobs and to lower…

Reforming Primary Health Care in Middle-Income Countries: The Good, the Bad, and the Ugly

18 July 2022

…A., Cubi-Molla, P. and Jofre-Bonet, M., 2022. Discontinuation of Performance-Based Financing in Primary Health Care: Impact on Family Planning and Maternal and Child Health. International Journal of Health Economics and…